| Incorporating quantitative patient preference data into healthcare decision making processes: is HTA falling behind? DJ Mott The Patient-Patient-Centered Outcomes Research 11 (3), 249-252, 2018 | 33 | 2018 |
| Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy DJ Mott, M Najafzadeh Expert review of pharmacoeconomics & outcomes research 16 (1), 33-39, 2016 | 18 | 2016 |
| Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? DJ Mott, KK Shah, JM Ramos-Goñi, NJ Devlin, O Rivero-Arias Medical Decision Making 41 (5), 584-596, 2021 | 12 | 2021 |
| Challenges in valuing temporary health states for economic evaluation: a review of empirical applications of the chained time trade-off method J Stoniute, DJ Mott, J Shen Value in Health 21 (5), 605-611, 2018 | 9 | 2018 |
| Conducting a time trade-off study alongside a clinical trial: a case study and recommendations J Shen, S Hill, D Mott, M Breckons, L Vale, R Pickard PharmacoEconomics-open 3 (1), 5-20, 2019 | 6 | 2019 |
| Reporting quality of marginal rates of substitution in discrete choice experiments that elicit patient preferences DJ Mott, N Chami, T Tervonen Value in Health 23 (8), 979-984, 2020 | 4 | 2020 |
| A multinational European study of patient preferences for novel diagnostics to manage antimicrobial resistance DJ Mott, G Hampson, MJ Llewelyn, J Mestre-Ferrandiz, MM Hopkins Applied health economics and health policy 18 (1), 69-79, 2020 | 3 | 2020 |
| Public preferences for health gains and cures: a discrete choice experiment G Hampson, D Mott, N Devlin, K Shah Office of Health Economics, London, 2019 | 3 | 2019 |
| Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments? P Cubi-Molla, D Mott, N Henderson, B Zamora, M Grobler, M Garau Office of Health Economics Research Papers, 2021 | 1 | 2021 |
| PCN382-quality of life in long-term cancer survivors: Implications for future health technology assessments in oncology P Cubi-Molla, DJ Mott, K Shah, M Herdman, Y Summers, C Tsuchiya, ... Value in Health 21, S79, 2018 | 1 | 2018 |
| How is Quality of Life Measured for Health Technology Assessments? D Mott, G Kumar, C Sampson, M Garau Briefings, 2021 | | 2021 |
| Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot Study DJ Mott, I Leslie, KK Shah, J Rowell, N Scheuer PharmacoEconomics - Open, 2021 | | 2021 |
| A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE H Payne, A Robinson, B Rappe, S Hilman, U De Giorgi, S Joniau, ... International Journal of Cancer, 2021 | | 2021 |
| What aspects of health and quality of life are important to people? K Shah, B Mulhern, M Janssen, P Cubi-Molla, D Mott QUALITY OF LIFE RESEARCH 28, S138-S138, 2019 | | 2019 |
| Comparing Alternative Choice Models of Heterogeneity in the Valuation of Children’s Health O Rivero-Arias, D Mott, K Shah, JM Ramos-Goñi, N Devlin 2019 World Congress on Health Economics, 2019 | | 2019 |
| How do preferences for public health interventions differ? a case study using a weight loss maintenance intervention DJ Mott Newcastle University, 2018 | | 2018 |
Koonal ShahNational Institute for Health and Care ExcellenceVerifierad e-postadress på nice.org.uk
